psalexa
P&S Market Research - A market research firm

Acute Back Pain Therapeutics Pipeline Analysis

Acute Back Pain Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11277
Available Format:

Acute back pain is the constant and sharp pain at the back that occurs when person falls or lifts something heavy and gradually becomes worse. According to researchers, acute back pain can be caused by ruptured disks, spasms, disk breakdown, and tense muscles. Acute back pain is also associated with various diseases and conditions such as scoliosis, arthritis, pregnancy, kidney stones, endometriosis, spondylolisthesis, and infections. Acute back pain can be diagnosed by blood test, computed tomography, magnetic resonance imaging, and X-rays. Thar Pharmaceuticals, Inc. is in the process of developing T109 as a non-narcotic therapy, for the treatment of acute back pain. Nektar Therapeutics is in the process of developing NKTR-181 as a selective mu-opioid agonist for the treatment of acute back pain. Some of the companies having the pipeline of acute back pain include Nektar Therapeutics, Thar Pharmaceuticals, Inc., and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry